Brigitt Raux
Papers
1
Total Citations
72
H-Index
1
About
Brigitt Raux is a medicinal chemist whose work bridges the gap between fragment-based drug discovery and practical lead optimization. Her research focuses on developing automated, cost-efficient strategies to streamline the hit-to-lead (H2L) process—a critical bottleneck in early-stage drug development. In her most cited work, "Integrated Strategy for Lead Optimization Based on Fragment Growing," Raux introduced the Diversity-Oriented-Target-Focused-Synthesis (DOTFS) approach, which combines fragment growing with targeted synthesis to accelerate the optimization of promising hits into viable leads. This methodology addresses a long-standing challenge in the field: the time- and resource-intensive nature of H2L optimization. With 72 citations, the paper has been influential among researchers seeking to automate and rationalize lead generation. Raux’s contributions are particularly valuable for teams working in academic drug discovery and small biotech settings, where efficiency is paramount. By integrating computational design with synthetic strategy, she has helped pave the way for more systematic and reproducible approaches to lead optimization, making her a notable figure in modern medicinal chemistry.
Research Focus
Key Achievements
Top Papers
- 1